Skip to main content
. 2014 May 3;14:312. doi: 10.1186/1471-2407-14-312

Table 5.

Clinicopathological characteristics according to molecular biomarkers in nGGO

  EGFR ALK P value*
N
119
6
 
Age
63.50 ± 9.11
60.00 ± 12.05
0.571
Sex
M:F = 43:76
M:F = 2:4
0.889
PYR
5.805 ± 14.426
0.750 ± 1.173
0.942
Pathologic stage
117†
6
0.001
  0
6
0
 
  IA
87
1
 
  IB
18
3
 
  IIA
1
1
 
  IIB
2
0
 
  IIIA
3
1
 
  IIIB
0
0
 
Nodal involvement
5
2
0.003
Histologic invasiveness
118**
6
0.351
  AIS
6
0
 
  MIA
11
0
 
  IA
101
6
 
Maximal diameter
22.387 ± 9.876
33.583 ± 13.736
0.032
Solid diameter
11.133 ± 11.229
23.217 ± 16.906
0.032
TDR 0.702 ± 0.295 0.533 ± 0.327 0.225

*P value: EGFR vs. ALK.

†Data for pathologic stage were unavailable for 2 patients.

**Data for histologic invasiveness were unavailable for 1 patient.